Anticoagulant potential of sulfated galactofucan Turbinaria decurrens (Bory de Saint-Vincent, 1828) in human umbilical vein endothelial cells: A marine-derived approach to thrombotic disorder management
IF 4.5 2区 生物学Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Ans Mariya George , Kajal Chakraborty , P. Sreeshma , Ashwin Ashok Pai , Silpa Kunnappilly Paulose
{"title":"Anticoagulant potential of sulfated galactofucan Turbinaria decurrens (Bory de Saint-Vincent, 1828) in human umbilical vein endothelial cells: A marine-derived approach to thrombotic disorder management","authors":"Ans Mariya George , Kajal Chakraborty , P. Sreeshma , Ashwin Ashok Pai , Silpa Kunnappilly Paulose","doi":"10.1016/j.algal.2025.104258","DOIUrl":null,"url":null,"abstract":"<div><div>Sulfated galactofucans from the Sargassaceae family are garnering increasing attention for their therapeutic potential, especially in the management of thrombotic disorders, which are major contributors to disease and mortality. While conventional anticoagulants are effective, their use is constrained by bleeding risks and adverse effects, prompting the search for safer alternatives. This study explores the anticoagulant potential of TDP-3, a sulfated galactofucan isolated from <em>Turbinaria decurrens</em>, with the proposed structure [→4)-3-O-SO<sub>3</sub><sup>−</sup>-<em>α</em>-Fuc<em>p</em>-(1 → 4)-<em>β</em>-Gal<em>p</em>-(1→], in human umbilical vein endothelial cells (HUVECs). TDP-3 (25 <em>μ</em>g/mL) significantly prolonged activated partial thromboplastin time (aPTT: 112.45 s) and prothrombin time (PT: 93.80 s), indicating its ability to interfere with both intrinsic as well as extrinsic coagulation pathways. TDP-3 effectively reduced thrombin production to 49 %, with a significant decrease of Factor Xa (FXa) expression (6.28-fold) and phospho-MARCKS (p-MARCKS) expression (84.1 %). Furthermore, TDP-3 inhibited thrombin-catalyzed fibrin polymerization by 79.19 % and reduced intracellular calcium mobilization by 33.65 %. The compound also demonstrated notable antiplatelet activity, reducing ADP-induced platelet aggregation to 82.9 %. TDP-3 consists mainly of <em>α-</em>(1 → 4)-linked fucose monomers connected to <em>β</em>-galactose, with sulfate groups at the 3-<em>O</em> position, forming a repeating chain. The superior anticoagulant potential of TDP-3 can be attributed to its electronegative sulfate and hydroxyl groups, which modulate physicochemical characteristics, including molecular polarizability and topological polar surface area favorably, thereby enhancing hydrogen bonding interactions with key receptors in coagulation pathways. These findings position TDP-3 as a promising natural anticoagulant with potential therapeutic applications for managing thrombotic disorders. Its potential as a functional food further contributes to the expanding field of marine-derived anticoagulants.</div></div>","PeriodicalId":7855,"journal":{"name":"Algal Research-Biomass Biofuels and Bioproducts","volume":"90 ","pages":"Article 104258"},"PeriodicalIF":4.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Algal Research-Biomass Biofuels and Bioproducts","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211926425003698","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Sulfated galactofucans from the Sargassaceae family are garnering increasing attention for their therapeutic potential, especially in the management of thrombotic disorders, which are major contributors to disease and mortality. While conventional anticoagulants are effective, their use is constrained by bleeding risks and adverse effects, prompting the search for safer alternatives. This study explores the anticoagulant potential of TDP-3, a sulfated galactofucan isolated from Turbinaria decurrens, with the proposed structure [→4)-3-O-SO3−-α-Fucp-(1 → 4)-β-Galp-(1→], in human umbilical vein endothelial cells (HUVECs). TDP-3 (25 μg/mL) significantly prolonged activated partial thromboplastin time (aPTT: 112.45 s) and prothrombin time (PT: 93.80 s), indicating its ability to interfere with both intrinsic as well as extrinsic coagulation pathways. TDP-3 effectively reduced thrombin production to 49 %, with a significant decrease of Factor Xa (FXa) expression (6.28-fold) and phospho-MARCKS (p-MARCKS) expression (84.1 %). Furthermore, TDP-3 inhibited thrombin-catalyzed fibrin polymerization by 79.19 % and reduced intracellular calcium mobilization by 33.65 %. The compound also demonstrated notable antiplatelet activity, reducing ADP-induced platelet aggregation to 82.9 %. TDP-3 consists mainly of α-(1 → 4)-linked fucose monomers connected to β-galactose, with sulfate groups at the 3-O position, forming a repeating chain. The superior anticoagulant potential of TDP-3 can be attributed to its electronegative sulfate and hydroxyl groups, which modulate physicochemical characteristics, including molecular polarizability and topological polar surface area favorably, thereby enhancing hydrogen bonding interactions with key receptors in coagulation pathways. These findings position TDP-3 as a promising natural anticoagulant with potential therapeutic applications for managing thrombotic disorders. Its potential as a functional food further contributes to the expanding field of marine-derived anticoagulants.
期刊介绍:
Algal Research is an international phycology journal covering all areas of emerging technologies in algae biology, biomass production, cultivation, harvesting, extraction, bioproducts, biorefinery, engineering, and econometrics. Algae is defined to include cyanobacteria, microalgae, and protists and symbionts of interest in biotechnology. The journal publishes original research and reviews for the following scope: algal biology, including but not exclusive to: phylogeny, biodiversity, molecular traits, metabolic regulation, and genetic engineering, algal cultivation, e.g. phototrophic systems, heterotrophic systems, and mixotrophic systems, algal harvesting and extraction systems, biotechnology to convert algal biomass and components into biofuels and bioproducts, e.g., nutraceuticals, pharmaceuticals, animal feed, plastics, etc. algal products and their economic assessment